Senate Health Committee Chair Sanders Once Again Urges Biden Administration to Act to Lower Outrageous Price of Alzheimer Treatment, Costly New Prescription Drugs
July 11, 2023
July 11, 2023
WASHINGTON, July 11 -- Sen. Bernie Sanders, I-Vermont, chair of the Senate Health, Education, Labor and Pensions Committee, issued the following news release and letter:
Following the Food and Drug Administration's (FDA) full approval of the Alzheimer's drug Leqembi, Sen. Bernie Sanders (I-Vt.), chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Monday sent a follow-up letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becer . . .
Following the Food and Drug Administration's (FDA) full approval of the Alzheimer's drug Leqembi, Sen. Bernie Sanders (I-Vt.), chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Monday sent a follow-up letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becer . . .